Cierra N. Sharp

Cierra N. Sharp

May 23, 2016

Group 6 Copy 31
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Urban Pollination: sustain native bees & urban crops

    Bee activity on our crop flowers is crucial to human food security, but bees are also declining around the...

    Cannibalism in Giant Tyrannosaurs

    This is the key question we hope to answer with this study. This project is to fund research into a skull...

    Seattle HiveBio Community Lab

    Thank you to everyone who has supported HiveBio thus far. As of April 17th we've reached our basic funding...

    Backer Badge Funded